Cargando…

Leptomeningeal disease in histone-mutant gliomas

BACKGROUND: The 2016 WHO classification described a subtype of midline gliomas harboring histone 3 (H3) K27M alterations, and the 2021 edition added a new subtype of hemispheric diffuse gliomas with H3 G34R/V mutations. The incidence and clinical behavior of leptomeningeal disease (LMD) in these pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diaz, Maria, Rana, Satshil, Silva Correia, Carlos Eduardo, Reiner, Anne S, Lin, Andrew L, Miller, Alexandra M, Graham, Maya S, Chudsky, Sofia, Bale, Tejus A, Rosenblum, Marc, Karajannis, Matthias A, Pentsova, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281361/ https://www.ncbi.nlm.nih.gov/pubmed/37346983 http://dx.doi.org/10.1093/noajnl/vdad068

Ejemplares similares

Histone-mutant glioma presenting as diffuse leptomeningeal disease
por: Nadkarni, Tanvi, et al.
Publicado: (2021)

EPCT-10. DEBIO1347, AN ORAL FGFR INHIBITOR: RESULTS FROM A SINGLE CENTER STUDY IN RECURRENT/REFRACTORY FGFR ALTERED PEDIATRIC GLIOMAS
por: Farouk Sait, Sameer, et al.
Publicado: (2021)

The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low‐grade gliomas and glioneuronal tumors
por: Bale, Tejus A., et al.
Publicado: (2022)

Quantitative cerebrospinal fluid circulating tumor cells are a potential biomarker of response for proton craniospinal irradiation for leptomeningeal metastasis
por: Wijetunga, N Ari, et al.
Publicado: (2021)

METB-07. MINIMALLY-INVASIVE DIAGNOSIS OF DIFFUSE LEPTOMENINGEAL GLIONEURONAL TUMOR (DLGNT) USING CEREBROSPINAL FLUID CELL-FREE DNA SEQUENCING IN PEDIATRIC AND YOUNG ADULT PATIENTS
por: Larsen, Alexandra Giantini, et al.
Publicado: (2023)

Histone-Mutant Glioma: Molecular Mechanisms, Preclinical Models, and Implications for Therapy
por: Graham, Maya S., et al.
Publicado: (2020)

Leptomeningeal metastatic cells adopt two phenotypic states
por: Remsik, Jan, et al.
Publicado: (2020)

Value of [(18)F]-FDG positron emission tomography in patients with recurrent glioblastoma receiving bevacizumab
por: Graham, Maya S, et al.
Publicado: (2020)

HGG-35. Radiation Induced High Grade Gliomas: A Single Center Experience
por: Joshirao, Mrinal, et al.
Publicado: (2022)

Pharmacoresistant seizures and IDH mutation in low-grade gliomas
por: Correia, Carlos Eduardo, et al.
Publicado: (2021)

Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults
por: Schulte, Jessica D, et al.
Publicado: (2020)

YAP1-MAML2 fusion in a pediatric NF2-wildtype intraparenchymal brainstem schwannoma
por: Karajannis, Matthias A., et al.
Publicado: (2022)

Recurrent TRAK1::RAF1 Fusions in pediatric low‐grade gliomas
por: Benhamida, Jamal K., et al.
Publicado: (2023)

Retrospective examination of pseudoprogression in IDH mutant gliomas
por: Wetzel, Ethan A, et al.
Publicado: (2023)

SPCR-02 NEUROCOGNITIVE FUNCTION IN PATIENTS WITH LEPTOMENINGEAL METASTASIS TREATED WITH PROTON CRANIOSPINAL IRRADIATION
por: Correa, Denise, et al.
Publicado: (2022)

Identification of Mutant Versions of the Spt16 Histone Chaperone That Are Defective for Transcription-Coupled Nucleosome Occupancy in Saccharomyces cerevisiae
por: Hainer, Sarah J., et al.
Publicado: (2012)

Dissecting Nucleosome Function with a Comprehensive Histone H2A and H2B Mutant Library
por: Jiang, Shuangying, et al.
Publicado: (2017)

Solitary Primary Leptomeningeal Glioma: Case Report
por: Kim, Young Goo, et al.
Publicado: (2013)

ETMM-03. CANCER CELLS DEPLOY LIPOCALIN- 2 TO COLLECT LIMITING IRON IN LEPTOMENINGEAL METASTASIS
por: Chi, Yudan, et al.
Publicado: (2021)

Tracking Tumor Evolution in Glioma through Liquid Biopsies of Cerebrospinal Fluid
por: Miller, Alexandra M., et al.
Publicado: (2019)

IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat
por: Sears, Thomas K., et al.
Publicado: (2021)

Leptomeningeal disease and tumor dissemination in a murine diffuse intrinsic pontine glioma model: implications for the study of the tumor-cerebrospinal fluid-ependymal microenvironment
por: Pan, Shelei, et al.
Publicado: (2022)

Leptomeningeal Metastasis in Gliomas : Clinical Characteristics and Risk Factors
por: Yang, Jeyul, et al.
Publicado: (2023)

Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults
por: Picart, Thiébaud, et al.
Publicado: (2021)

Collagen deposition within brain metastases is associated with leptomeningeal failure after  cavity-directed radiosurgery
por: Abdulhaleem, Mohammed, et al.
Publicado: (2023)

Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer
por: Malani, Rachna, et al.
Publicado: (2020)

Detection of Leptomeningeal Disease Using Cell-Free DNA From Cerebrospinal Fluid
por: White, Michael D., et al.
Publicado: (2021)

Leptomeningeal spread in high-grade gliomas: Is surgery or adjuvant therapy after leptomeningeal spread associated with survival benefit?
por: Zhong, Shuai, et al.
Publicado: (2023)

Early volumetric, perfusion, and diffusion MRI changes after mutant isocitrate dehydrogenase (IDH) inhibitor treatment in IDH1-mutant gliomas
por: Cho, Nicholas S, et al.
Publicado: (2022)

CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomas
por: Hickman, Richard A., et al.
Publicado: (2023)

FGFR- gene family alterations in low-grade neuroepithelial tumors
por: Bale, Tejus A.
Publicado: (2020)

ABL1 and ABL2 promote medulloblastoma leptomeningeal dissemination
por: Jones, Jill K, et al.
Publicado: (2023)

Olaparib treatment for BRCA-mutant ovarian cancer with leptomeningeal disease
por: Bangham, Madeleine, et al.
Publicado: (2016)

Prognostic value of O(6)-methylguanine-DNA methyltransferase methylation in isocitrate dehydrogenase mutant gliomas
por: Lam, Keng, et al.
Publicado: (2022)

A single-institution retrospective analysis of pathologically determined malignant transformation in IDH mutant glioma patients
por: Liu, Vicki, et al.
Publicado: (2023)

The first-in-human phase I study of a brain-penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomas
por: Natsume, Atsushi, et al.
Publicado: (2022)

Response of Leptomeningeal Dissemination of Anaplastic Glioma to Temozolomide: Experience of Two Cases
por: Bae, Jin Woo, et al.
Publicado: (2017)

Glioma with Leptomeningeal Spread Mimics Chronic Meningoencephalitis in a Young Adult
por: Becker, Ann-Kristin, et al.
Publicado: (2021)

Evaluation of neurapheresis therapy in vitro: a novel approach for the treatment of leptomeningeal metastases
por: Ejikeme, Tiffany, et al.
Publicado: (2020)

Diversity and Divergence of Dinoflagellate Histone Proteins
por: Marinov, Georgi K., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kg4is3mjmf2ma31hlv0ie1iu5e